Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine versus tetracaine for oculocardiac reflex prevention in strabismus surgery
IRCT20150106020588N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of atropine, tetracaine and artificial tears in strabismus (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Heart rate and Blood pressure. Started Jun 2020; status: completed.
02
Drugs
atropinetetracaineartificial tears
03
Conditions
strabismus
Beyond the preview
Go deeper on IRCT20150106020588N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150106020588N8.